COLLABORATION FIELD

COLLABORATION FIELD. Vaccines for the prevention or treatment of ovarian cancer and other cancers which express the Anti-Mullerian Hormone Receptor 2 (AMHR2) protein, including an Anti-Mullerian Hormone Receptor 2 protein with an extracellular domain (AMHR2-ED), corresponding adjuvants and any companion diagnostics.